Weekly round-up #256

One Health and a retrospective study of laboratory – based melioidosis surveillance in Songkhla and Phatthalung Provinces of southern Thailand


VALIDATE Seminar Later today - One Health and a retrospective study of laboratory-based melioidosis surveillance in Thailand

It is well-recognized that melioidosis is endemic in most parts of Thailand.In this seminar, Dr Apichai Tuanyok will discuss his team’s “One Health” approach and multidisciplinary research to investigate the epidemiology of melioidosis in the south of the country. 

The talk starts at 15:00 GMT and you can request access by emailing VALIDATE@ndm.ox.ac.uk



You can find a list of all relevant external funding we've spotted for our members on our external funding page.​​

Training Opportunities and Events:​​​​​​


Job Opportunities:

Other relevant career opportunities are on our jobs page.




Check out our Publications Page for members' publications and email VALIDATE@ndm.ox.ac.uk if you have a paper you would like us to include.


Highlights on Twitter this week:

Medical Express reported on 100 years of BCG, the times India discussed the many claimed uses for the vaccine, and the Asian Times reported a 25% increase in leprosy cases in India.  Nature Asia reported finding alternatives to using Shark derived compounds in vaccines, Prof Alice Turner’s team received $1.8 million dollars for BCG research, and BACTIVAC secured £1 million in funding from Wellcome. The BSI promoted its Career Enhancing Grants and announced its 2023 awards for Leadership, Diversity, and Outstanding Team in immunology research. Nature Careers called for greater openness in US science funding, the worrying lack of reviewers willing to support the peer review system, and the financial constraints faced by Post-Docs in the US. Keep up to date with all the relevant news and opportunities by following @NetworkVALIDATE on Twitter.


Published: 22 February 2023